Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways

• Published in: Virology (New York, N.Y.) Vol. 371; no. 1; pp. 139 - 154
• Main Authors: Xie, Jianping, Ajibade, Adetola Olalekan, Ye, Fengchun, Kuhne, Kurt, Gao, Shou-Jiang
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 05-02-2008
• Subjects: AP-1; Herpesvirus 8, Human - physiology; Human herpesvirus 8; Humans; Infectious Disease; JNK Mitogen-Activated Protein Kinases - physiology; Kaposi's sarcoma; Kaposi's sarcoma-associated herpesvirus; KSHV; MAPK pathways; Mitogen-Activated Protein Kinase Kinases - physiology; p38 Mitogen-Activated Protein Kinases - physiology; Reactivation; RTA; TPA; Virus Activation; Virus Latency; Reactivation; TPA; KSHV; Kaposi's sarcoma; MAPK pathways; AP-1; RTA
• ISSN: 0042-6822; 1096-0341
• DOI: 10.1016/j.virol.2007.09.040

Abstract Lytic replication of Kaposi's sarcoma-associated herpesvirus (KSHV) promotes the progression of Kaposi's sarcoma (KS), a dominant malignancy in patients with AIDS. While 12- O -tetradecanoyl-phorbol-13-acetate (TPA)-induced KSHV reactivation from latency is mediated by the protein kinase C δ and MEK/ERK mitogen-activated protein kinase (MAPK) pathways, we have recently shown that the MEK/ERK, JNK and p38 MAPK pathways modulate KSHV lytic replication during productive primary infection of human umbilical vein endothelial cells [Pan, H., Xie, J., Ye, F., Gao, S.J., 2006. Modulation of Kaposi's sarcoma–associated herpesvirus infection and replication by MEK/ERK, JNK, and p38 multiple mitogen–activated protein kinase pathways during primary infection. J. Virol. 80 (11), 5371–5382]. Here, we report that, besides the MEK/ERK pathway, the JNK and p38 MAPK pathways also mediate TPA-induced KSHV reactivation from latency. The MEK/ERK, JNK and p38 MAPK pathways were constitutively activated in latent KSHV-infected BCBL-1 cells. TPA treatment enhanced the levels of activated ERK and p38 but not those of activated JNK. Inhibitors of all three MAPK pathways reduced TPA-induced production of KSHV infectious virions in BCBL-1 cells in a dose-dependent fashion. The inhibitors blocked KSHV lytic replication at the early stage(s) of reactivation, and reduced the expression of viral lytic genes including RTA, a key immediate-early transactivator of viral lytic replication. Activation of MAPK pathways was necessary and sufficient for activating the promoter of RTA. Furthermore, we showed that the activation of RTA promoter by MAPK pathways was mediated by their downstream target AP-1. Together, these findings suggest that MAPK pathways might have general roles in regulating the life cycle of KSHV by mediating both viral infection and switch from viral latency to lytic replication.